ONK Therapeutics and Trinity researchers seek improved cancer therapies

(Trinity College Dublin) ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has been awarded an Innovation Partnership Programme (IPP) grant by Enterprise Ireland (EI) to fund collaborative research at Trinity College Dublin, Ireland, led by Dr. David Finlay to optimize the metabolism and engineering of NK cells for improved cancer therapies.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news